Nedaplatin belongs to the second generation of platinum chemotherapy drugs, which can be used in various stages of cancer in clinic. It belongs to broad-spectrum anticancer drugs and is not designated for a certain clinical stage.
Mainly suitable for digestive tract tumors, lung tumors, ovarian and uterine tumors, especially esophageal squamous cell carcinoma and lung squamous cell carcinoma, nedaplatin is the first line recommendation.